A new study has further supported psilocybin's potential to treat depression, wh...
Coinfections can complicate disease management and hence continued surveillance ...
At the London Biotechnology Show, Microsoft’s senior director of life sciences d...
Zenas signed a licencing deal for Asia-Pacific territories for the bispecific an...
Cipla and Glenmark Pharmaceuticals are recalling specific products from the US m...
Lantern Pharma has entered into a partnership with Oregon for optimising the dev...
The UK MHRA approved two formulations of ViiV Healthcare’s cabotegravir, offerin...
Sentynl Therapeutics has announced the acquisition of Zokinvy programme from Eig...
Amgen announced updates in the obesity space, with topline data for MariTide exp...
ImmunityBio has entered a worldwide agreement with the Serum Institute of India ...
Ibutamoren mesylate is under clinical development by Lumos Pharma and currently ...
UK liquid biopsy company, Angle, has agreed a supplier agreement with AstraZenec...
The FDA has awarded the designation following a review of initial safety and eff...
Despite failing to get an approval for type 1 diabetes in 2019, Lexicon plans to...
Techniques such as rapid nanomotion-based susceptibility testing, and MALDI-TOF-...
The NHS in the UK has announced plans to offer Pfizer's Voxelotor (Oxbryta), a n...
